Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization

Clinical trial NCT06229080 · COMPLETED

Trial details

NCT number: NCT06229080
Sponsor: Next Biomedical Co., Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Cancer (Primary and Metastatic)

Start date: 2023-03-15
Primary completion: 2025-01-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.